
Small venture firm that works closely with early-stage founders from the earliest stage

Venture capital firm investing in life sciences, information technology and energy technology companies

Three fields make up the investment map at Presidio Partners: life sciences, IT and energy technology. The firm says it brings a fresh approach to venture capital, one that rests on active portfolio management, transparency, teamwork and accountability, and that the team brings over a quarter of a century of venture, operating and financial management work to each opportunity it finds.
The team describes a mindset it calls "what matters most". Rather than spreading its attention evenly, it concentrates its intellectual effort on the value drivers it believes produce the greatest returns for both the entrepreneurs it backs and the investors who fund the firm.
For each major investment the firm assigns two of its own team members. Its reasoning is that two minds are likely better than one: two distinct perspectives are meant to encourage collaboration and keep each deal accountable.
The firm says it works to build a high degree of transparency, trust and accountability, which it believes both its portfolio companies and its limited partners value. In practice it describes frank discussions in which the team shares what it really thinks, whether the news is good or bad.
The firm is unusually open about its record. It acknowledges that it has overfunded big ideas before their time and fallen for technologies that later became uncompetitive. It says it studies those errors, makes the changes they call for and tries to emerge stronger.
Its portfolio pages are organized under information technology, life sciences and energy technology, the three areas where it says it looks for the best opportunities.
Presidio Partners is a venture capital firm that invests in three fields: life sciences, information technology and energy technology. It stresses active management of its portfolio, openness and accountability.
Entrepreneurs and their investors. Recent news mentions investments in Exela Pharma Sciences to support United States drug manufacturing, the executive team at Solaria Corporation, and a development milestone at Altimmune toward a single-dose intranasal COVID-19 vaccine.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Presidio Partners.
Similar listings buyers compare against this one.

Small venture firm that works closely with early-stage founders from the earliest stage

Angel investor group giving seed funding and management advice to climate technology startups

Massachusetts venture fund backing early-stage deep tech and running a technology transfer centre

Venture capital firm investing in early-stage technology companies in Indonesia and Southeast Asia

An early-stage investor backing technology startups from their earliest days, mostly across Europe

Corporate venture arm of a renewable energy group backing early-stage energy technology companies

French sustainable private-equity manager covering infrastructure, venture capital and private debt for institutional and retail investors

Austin venture capital firm backing early-stage applied AI companies across North America
Everything here links back to the same verified catalogue. Pick your next stop.